[A comparative evaluation of the immune status of patients with squamous-cell cancer of the oral mucosa at different stages of combined treatment].
Shifts in immunity values were detected in 160 patients with oral cancer before specific therapy and at all stages of multiple-modality treatment. High diagnostic significance of measuring concentrations of circulating immune complexes in the serum for prediction of tumor relapse or metastases is demonstrated.
Matchin
A A
AA
Smoliagin
A I
AI
D000328:Adult; D000917:Antibody Formation; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis / Q000276:immunology* / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D008297:Male; D008875:Middle Aged; D009061:Mouth Mucosa; D009062:Mouth Neoplasms / Q000175:diagnosis / Q000276:immunology* / Q000628:therapy; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000276:immunology / Q000628:therapy; D011379:Prognosis; D013997:Time Factors
Sravnitel'naia otsenka immunnogo statusa bol'nykh ploskokletochnym rakom slizistoĭ obolochki organov polosti rta na razlichnykh étapakh kombinirovannogo lecheniia.